GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Applied DNA Sciences Inc (FRA:UDJ) » Definitions » EBITDA Margin %

Applied DNA Sciences (FRA:UDJ) EBITDA Margin % : -368.81% (As of Mar. 2024)


View and export this data going back to 2001. Start your Free Trial

What is Applied DNA Sciences EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Applied DNA Sciences's EBITDA for the three months ended in Mar. 2024 was €-3.16 Mil. Applied DNA Sciences's Revenue for the three months ended in Mar. 2024 was €0.86 Mil. Therefore, Applied DNA Sciences's EBITDA margin for the quarter that ended in Mar. 2024 was -368.81%.


Applied DNA Sciences EBITDA Margin % Historical Data

The historical data trend for Applied DNA Sciences's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Applied DNA Sciences EBITDA Margin % Chart

Applied DNA Sciences Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
EBITDA Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -149.66 -634.47 -129.40 -69.78 -71.75

Applied DNA Sciences Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -53.53 -86.07 -492.34 -391.68 -368.81

Competitive Comparison of Applied DNA Sciences's EBITDA Margin %

For the Diagnostics & Research subindustry, Applied DNA Sciences's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Applied DNA Sciences's EBITDA Margin % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Applied DNA Sciences's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Applied DNA Sciences's EBITDA Margin % falls into.



Applied DNA Sciences EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Applied DNA Sciences's EBITDA Margin % for the fiscal year that ended in Sep. 2023 is calculated as

EBITDA Margin %=EBITDA (A: Sep. 2023 )/Revenue (A: Sep. 2023 )
=-8.987/12.525
=-71.75 %

Applied DNA Sciences's EBITDA Margin % for the quarter that ended in Mar. 2024 is calculated as

EBITDA Margin %=EBITDA (Q: Mar. 2024 )/Revenue (Q: Mar. 2024 )
=-3.157/0.856
=-368.81 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Applied DNA Sciences  (FRA:UDJ) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


Applied DNA Sciences EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Applied DNA Sciences's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Applied DNA Sciences (FRA:UDJ) Business Description

Traded in Other Exchanges
Address
50 Health Sciences Drive, Stony Brook, New York, NY, USA, 11790
Applied DNA Sciences Inc is a biotechnology company developing and commercializing technologies to produce and detect deoxyribonucleic acid (DNA) nd ribonucleic acid (RNA). The company operates in three business segments- Therapeutic DNA Production Services, MDx Testing Services, and DNA Tagging and Security Products and Services. It generates majority of its revenue from the MDx Testing Services which is involved in performing and developing clinical molecular diagnostic and genetic tests and clinical laboratory testing services. The company provides its products and services under the brand of Applied DNA Sciences, SigNature molecular tags, SigNature T molecular tags, fiberTyping, SigNify and others.

Applied DNA Sciences (FRA:UDJ) Headlines

No Headlines